Enlivex Therapeutics Ltd. (TLV:ENLV)
366.00
-12.70 (-3.35%)
Apr 1, 2025, 4:39 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 79.44 million as of April 1, 2025. Its market cap has decreased by -72.72% in one year.
Market Cap
79.44M
Enterprise Value
-8.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
366.00
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 79.44M, a decrease of -78.42%. That is a compound annual growth rate of -22.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 63.85B |
Danel (Adir Yeoshua) | 2.16B |
Kamada | 1.46B |
Bait Bakfar | 897.25M |
Novolog (Pharm-Up 1966) | 845.44M |
Ilex Medical | 741.81M |
BrainsWay | 667.22M |
SofWave Medical | 555.35M |